Analysed ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) News Sources
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
30-06-2026
yahoo.com
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results
14-07-2026
yahoo.com
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
14-07-2026
yahoo.com
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant
21-07-2026
yahoo.com
Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
21-07-2026
yahoo.com
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
23-07-2026
yahoo.com
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
10-08-2026
yahoo.com
What is the current price of ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ)?
The current price of ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) is $0.041.
ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) since the previous trading day is $0.0099.
ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) since the previous trading day is 31.8328%.
What is the most recent average sentiment score for ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ)?
The most recent average sentiment score for ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) is 48 out of 100.
What is the most recent average sentiment for ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ)?
The most recent sentiment for ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ) is .
SEC-8K** Filing Available For ENVOY MEDICAL INC-CW27 (COCHW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.